These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 11233456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
    Russell JM, Kornstein SG, Shea MT, McCullough JP, Harrison WM, Hirschfeld RM, Keller MB.
    J Clin Psychiatry; 2003 May; 64(5):554-61. PubMed ID: 12755659
    [Abstract] [Full Text] [Related]

  • 5. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.
    J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
    Baca E, Garcia-Garcia M, Porras-Chavarino A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
    [Abstract] [Full Text] [Related]

  • 8. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
    Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, Markowitz JC, Schlager DS, Kornstein SG, Davis SM, Harrison WM, Keller MB.
    J Clin Psychiatry; 1998 Nov; 59(11):608-19. PubMed ID: 9862607
    [Abstract] [Full Text] [Related]

  • 9. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
    Sechter D, Troy S, Paternetti S, Boyer P.
    Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
    Lepola U, Arató M, Zhu Y, Austin C.
    J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sertraline is more effective than imipramine in the treatment of non-melancholic depression: results from a multicentre, randomized study.
    Baca E, González de Chávez M, García-Toro M, Pérez-Arnau F, Porras-Chavarino A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):493-500. PubMed ID: 12691786
    [Abstract] [Full Text] [Related]

  • 15. Sertraline treatment of major depression in patients with acute MI or unstable angina.
    Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, Mclvor M, Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group.
    JAMA; 2002 Aug 14; 288(6):701-9. PubMed ID: 12169073
    [Abstract] [Full Text] [Related]

  • 16. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
    Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.
    J Clin Psychiatry; 1994 Jun 14; 55(6):234-41. PubMed ID: 8071277
    [Abstract] [Full Text] [Related]

  • 17. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
    Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.
    Arch Gen Psychiatry; 2007 Jun 14; 64(6):679-88. PubMed ID: 17548749
    [Abstract] [Full Text] [Related]

  • 18. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM, Brown EB, Gonzales JS, Munir R.
    J Clin Psychiatry; 2002 Mar 14; 63(3):232-40. PubMed ID: 11926723
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.
    Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E.
    BMJ; 2015 Sep 16; 351():h4320. PubMed ID: 26376805
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.